Behavior-based community detection in enterprise information networks

Methods and systems for detecting host community include modeling a target host's behavior based on historical events recorded at the target host. One or more original peer hosts having behavior similar to the target host's behavior are found by determining a distance in a latent space that embeds the historical events between events of the target host and events of the one or more original peer hosts. A security management action is performed based on behavior of the target host and the determined one or more original peer hosts.

SINGLE-MOTOR, DUAL-HYDRAULIC-CIRCUIT DRIVE SYSTEM FOR INDUSTRIAL MATERIALS-HANDLING VEHICLE AND METHOD FOR CONTROLLING THE SAME

A drive system for an industrial handling vehicle comprises an electric motor, a first pump, for example, a plunger pump, and a second pump, for example, a gear pump. The first pump is configured to provide hydraulic power for a travelling device of the industrial handling vehicle. The first pump and the travelling device are in a first hydraulic circuit. The second pump is configured to provide hydraulic power for a brake device and/or a steering device and/or a handling device of the industrial handling vehicle. The second pump, the brake device, the steering device, and the handling device are in a second hydraulic circuit isolated from the first hydraulic circuit. The electric motor is operatively coupled to both the first pump and the second pump, to drive them to operate.

BEHAVIOR-BASED HOST MODELING

Methods and systems for modeling host behavior in a network include determining a first probability function for observing each of a set of process-level events at a first host based on embedding vectors for the first event and the first host. A second probability function is determined for the first host issuing each of a set of network-level events connecting to a second host based on embedding vectors for the first host and the second host. The first and second probability functions are maximized to determine a set of likely process-level and network-level events for the first host. A security action is performed based on the modeled host behavior. 1. A method for modeling host behavior in a network , comprising:determining a first probability function for observing each of a set of process-level events at a first host based on embedding vectors for the first event and the first host;determining a second probability function for the first host issuing each of a set of network-level events connecting to a second host based on embedding vectors for the first host and the second host;maximizing the first and second probability functions to determine a set of likely process-level and network-level events for the first host; andperforming a security action based on the modeled host behavior.2. The method of claim 1 , wherein the set of process-level events and the set of network level events are historical events detected at the first host.3. The method of claim 1 , wherein maximizing the first and second probability functions comprises performing a negative sampling of the host-event pairs.4. The method of claim 3 , wherein maximizing the first and second probability functions further comprises mini-batch gradient descent using the negative sampling of the host-event pairs.5. The method of claim 3 , wherein the negative sampling approximates a maximized conditional probability that an event will occur at the target host.6. The method of claim 1 , wherein performing ...

PEER-BASED ABNORMAL HOST DETECTION FOR ENTERPRISE SECURITY SYSTEMS

Systems and methods for determining a risk level of a host in a network include modeling a target host's behavior based on historical events recorded at the target host. One or more original peer hosts having behavior similar to the target host's behavior are determined. An anomaly score for the target host is determined based on how the target host's behavior changes relative to behavior of the one or more original peer hosts over time. A security management action is performed based on the anomaly score.

An apparatus

An apparatus comprises a substantially horn shaped structure configured to amplify sound from a speaker of a device wherein the apparatus comprises packaging of the device.

HUMANIZED ANTI-EGFR ANTIBODY L4-H3 AND CODING GENE THEREOF

A humanized anti-EGFR antibody L4-H3 and gene encoding the antibody are disclosed. The antibody is composed of a heavy chain and a light chain. The amino acid sequence of the heavy chain variable region is shown as positions 1-145 of SEQ ID NO: 3, the heavy chain constant region is the heavy chain constant region of the human antibody IgG1, and the amino acid sequence of the light chain is shown as SEQ ID NO: 1.

Use of Favipiravir in treatment of coronavirus infection

The present application relates to a Favipiravir compound represented by Formula I, a geometric isomer, a pharmaceutically acceptable salt, a solvate and/or a hydrate thereof, and a pharmaceutical composition comprising the compound for treating a coronavirus infection.

SYSTEM AND METHOD FOR ACTIVITY DETERMINATION

Features are disclosed relating to determining an activity in which a user is (or has been) engaged. One such activity is the taking of steps (e.g., walking or running). Some embodiments described herein are directed to accurate detection and counting of steps made by a user wearing a device with step-detection functionality. The accurate step counting can be facilitated by detecting signatures of certain activities, and determining whether to count steps based on an analysis of acceleration data over various intervals and moving windows of time. 1. A device comprising:one or more sensors configured to detect acceleration; obtain acceleration data from the one or more sensors for a time interval;', 'determine that the acceleration data is not indicative of a non-step-related activity;', 'average the acceleration data for the time interval to obtain a mean acceleration vector;', 'project the mean acceleration vector on a gravity acceleration vector to obtain a projection;', 'identify a peak using a derivative based at least partly on the projection; and', 'determine that a user of the device has taken a step based at least partly on the identified peak., 'one or more physical computer processors configured to at least2. The device of claim 1 , wherein the one or more computer processors are configured to determine that the acceleration data is not indicative of a non-step-related activity by extracting one or more features from the acceleration data and analyzing the features to determine whether they correspond to features of data associated with a non-step-related activity.3. The device of claim 1 , wherein the non-step-related activity comprises driving claim 1 , eating claim 1 , brushing teeth claim 1 , or sleeping.4. The device of claim 1 , wherein the one or more computer processors are configured to determine that the acceleration data is not indicative of a non-step-related activity by analyzing the acceleration data with respect to data associated with ...

Method and system for measuring quality of service running on terminal, and device

A method for measuring quality of a service running on a terminal includes sending, by the terminal, a measurement request message to a network management device, where the measurement request message requests the network management device to measure the quality of the service, receiving, by the terminal, measurement configuration information from the network management device in response to the measurement request message, coloring a packet of a service stream within a preset measurement period according to the measurement configuration information to obtain a colored packet, and sending, by the terminal, at least one of quantity information or time stamp information of the colored packet to the network management device. Hence, the quality of the service running on the terminal is comprehensively measured.

Anti-epidermal growth factor receptor antibodies and uses thereof

The present invention discloses humanized anti-epidermal growth factor receptor antibodies, which have favorable binding activity (the binding affinity being 6.13×10-10 mol/L) and are able to inhibit the growth and migration of tumor cells. The present invention also discloses the preparation methods and uses of the antibodies.

ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODIES AND USES THEREOF

The present invention discloses humanized anti-epidermal growth factor receptor antibodies, which have favorable binding activity (the binding affinity being 5.09×10mol/L) and are able to inhibit the growth and migration of tumor cells. The present invention also discloses the preparation methods and uses of the antibodies. 1. An antibody , wherein the heavy chain variable region of the antibody has the amino acid sequence as set forth by SEQ ID NO. 3 , and the light chain of the antibody has the amino acid sequence as set forth by SEQ ID NO. 2.2. The antibody according to claim 1 , wherein the antibody comprises a heavy chain and the light chain claim 1 , and the heavy chain comprises the heavy chain variable region and a heavy chain constant region.3. The antibody according to claim 2 , wherein the heavy chain constant region comprises an amino acid sequence as set forth by SEQ ID NO. 11.4. An isolated DNA encoding the heavy chain variable region of claim 2 , or an isolated DNA encoding the light chain of .5. The isolated DNA according to claim 4 , wherein the isolated DNA encoding the heavy chain variable region comprises the following 1) claim 4 , 2) or 3):1) an isolated DNA molecule having the nucleotide sequence as set forth by SEQ ID NO. 6;2) an isolated DNA molecule, which hybridizes with the DNA sequence defined in 1) under stringent conditions, and which encodes the heavy chain variable region;3) an isolated DNA molecule encoding the heavy chain variable region, wherein an amino acid sequence encoding the heavy chain variable region contains sequence having more than 70% homology to amino acids at positions 51-70 starting from the N-terminal of SEQ ID NO. 3 (i.e., nucleotides at positions 153 bp-210 bp starting from the 5′ end of SEQ ID NO. 6);an isolated DNA encoding the light chain comprising the following I), II) or III):I) an isolated DNA molecule having the nucleotide sequence as set forth by SEQ ID NO. 5;II) an isolated DNA molecule, which hybridizes ...

Behavior-based host modeling

Methods and systems for modeling host behavior in a network include determining a first probability function for observing each of a set of process-level events at a first host based on embedding vectors for the first event and the first host. A second probability function is determined for the first host issuing each of a set of network-level events connecting to a second host based on embedding vectors for the first host and the second host. The first and second probability functions are maximized to determine a set of likely process-level and network-level events for the first host. A security action is performed based on the modeled host behavior.

Peer-based abnormal host detection for enterprise security systems

Systems and methods for determining a risk level of a host in a network include modeling a target host's behavior based on historical events recorded at the target host. One or more original peer hosts having behavior similar to the target host's behavior are determined. An anomaly score for the target host is determined based on how the target host's behavior changes relative to behavior of the one or more original peer hosts over time. A security management action is performed based on the anomaly score.

Humanized anti-EGFR antibody L4-H3 and coding gene thereof

A humanized anti-EGFR antibody L4-H3 and gene encoding the antibody are disclosed. The antibody is composed of a heavy chain and a light chain. The amino acid sequence of the heavy chain variable region is shown as positions 1-145 of SEQ ID NO: 3, the heavy chain constant region is the heavy chain constant region of the human antibody IgG1, and the amino acid sequence of the light chain is shown as SEQ ID NO: 1.

Estimating treatment effect of user interface changes using a state-space model

Examples described herein generally relate to a computer device including a memory, and at least one processor configured to evaluate a change to a user interface. The computer device monitor user interactions with the user interface prior to and after a change to the user interface. The monitoring includes collecting result metric data per user. The computer device divides users into a treated group and a control group based on whether each user engages in a particular interaction. The computer device generates a result metric time series for the treated group and a partitioned result metric time series for the control group. The computer device estimates a conditional distribution of the result metric and a counterfactual behavior using a Bayesian machine learning model based on the result metric time series. The computer device determines a treatment effect of the change to the user interface on the result metric data.

BEHAVIOR-BASED COMMUNITY DETECTION IN ENTERPRISE INFORMATION NETWORKS

Methods and systems for detecting host community include modeling a target host's behavior based on historical events recorded at the target host. One or more original peer hosts having behavior similar to the target host's behavior are found by determining a distance in a latent space that embeds the historical events between events of the target host and events of the one or more original peer hosts. A security management action is performed based on behavior of the target host and the determined one or more original peer hosts. 1. A method for detecting host community , comprising:modeling a target host's behavior based on historical events recorded at the target host;determining one or more original peer hosts having behavior similar to the target host's behavior by determining a distance in a latent space that embeds the historical events between events of the target host and events of the one or more original peer hosts; andperforming a security management action based on behavior of the target host and the determined one or more original peer hosts.2. The method of claim 1 , wherein determining one or more peer hosts comprises clustering hosts based on distance in the latent space.3. The method of claim 2 , wherein clustering comprises identifying a set of initial cluster centroids and iteratively updating the centroids after assigning hosts to a closest cluster.4. The method of claim 1 , further comprising embedding the historical events in a latent space using a negative sampling that approximates a maximized conditional probability that an event will occur at the target host.5. The method of claim 1 , wherein performing the security management action comprises determining an anomaly score based on a comparison between behavior of one or more new peer hosts and behavior of the one or more original peer hosts.6. The method of claim 1 , wherein performing the security management action comprises determining an anomaly score based on a similarity between new ...

ANTI-EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODIES AND USES THEREOF

The present invention discloses humanized anti-epidermal growth factor receptor antibodies, which have favorable binding activity (the binding affinity being 6.13×10 −10 mol/L) and are able to inhibit the growth and migration of tumor cells. The present invention also discloses the preparation methods and uses of the antibodies

Method and apparatus to detect scripted network traffic

A bot traffic detection system detects scripted network traffic. The bot traffic detection system may use a one-sided unsupervised machine learning technique to estimate distributions for human, non-scripted traffic (clean distributions). The clean distributions may be dynamically updated based on the latest traffic patterns. To estimate the clean distributions the bot traffic detection system may identify, for a certain subset of network traffic, feature values of the certain subset of network traffic that do not include bot traffic (clean buckets). Using clean traffic may provide more robust and stable behavior that can be tracked over time. Using the clean distributions, the bot traffic detection system may generate a rules table that indicates a likelihood that network traffic with a given combination of feature values is scripted network traffic. The bot traffic detection system may apply the rules table in real time to identify scripted network traffic.

Method and System for Measuring Quality of Service Running on Terminal, and Device

A method for measuring quality of a service running on a terminal includes sending, by the terminal, a measurement request message to a network management device, where the measurement request message requests the network management device to measure the quality of the service, receiving, by the terminal, measurement configuration information from the network management device in response to the measurement request message, coloring a packet of a service stream within a preset measurement period according to the measurement configuration information to obtain a colored packet, and sending, by the terminal, at least one of quantity information or time stamp information of the colored packet to the network management device. Hence, the quality of the service running on the terminal is comprehensively measured. 1. A method , comprising:sending, by a terminal, a measurement request message to a network management device, wherein the measurement request message requests the network management device to measure a quality of a service;receiving, by the terminal, measurement configuration information from the network management device in response to the measurement request message;coloring, by the terminal, a packet of a service stream within a preset measurement period according to the measurement configuration information to obtain a colored packet, wherein the service stream comprises a data stream of the service, and wherein the measurement configuration information comprises the preset measurement period; andsending, by the terminal, at least one of quantity information or time stamp information of the colored packet to the network management device.2. The method according to claim 1 , wherein coloring the packet of the service stream within the preset measurement period comprises coloring the packet of the service stream within the preset measurement period according to a preset coloring rule claim 1 , and wherein the preset coloring rule comprises coloring a bit of ...

Anti-epidermal growth factor receptor antibodies and uses thereof

The present invention discloses humanized anti-epidermal growth factor receptor antibodies, which have favorable binding activity (the binding affinity being 5.09×10-10 mol/L) and are able to inhibit the growth and migration of tumor cells. The present invention also discloses the preparation methods and uses of the antibodies.

Apparatus

An apparatus comprises a substantially horn shaped structure configured to amplify sound from a speaker of a device wherein the apparatus comprises packaging of the device. 129-. (canceled)30. An apparatus comprising:a substantially horn shaped structure configured to act as an acoustic filter for sound from a speaker of a device wherein the apparatus comprises packaging.31. An apparatus as claimed in claim 30 , wherein the apparatus comprises packaging of the device.32. An apparatus as claimed in claim 30 , wherein the acoustic filter amplifies sound from the speaker of the device.33. An apparatus according to wherein the horn shaped structure is configured to be modified from a packaging arrangement to an amplifying arrangement.34. An apparatus according to wherein the packaging arrangement is a flat arrangement and horn shaped structure is expandable to an amplifying arrangement.35. An apparatus according to wherein the apparatus further comprises a box.36. An apparatus according to wherein the horn shaped structure is integral with the box.37. An apparatus according to wherein the apparatus is configured to be an internal divider of a box in the flat arrangement.38. An apparatus according to wherein the box comprises a detachable portion adjacent to a mouth of the horn shaped structure.39. An apparatus according to wherein the apparatus comprises an interface configured to acoustically couple the speaker of the device with the horn shaped structure.40. An apparatus according to wherein the interface comprises a seal configured to abut the speaker for reducing sound wave leakage.41. An apparatus according to wherein a wall of the apparatus defines a portion of the horn such that when the apparatus cooperates with a surface of another object claim 30 , the apparatus and the surface define the complete horn shaped structure.42. An apparatus according to wherein the surface of the another object is the base of the box.43. An apparatus according to wherein the ...

USE OF FAVIPIRAVIR IN TREATMENT OF CORONAVIRUS INFECTION

The present application relates to a Favipiravir compound represented by Formula I, a geometric isomer, a pharmaceutically acceptable salt, a solvate and/or a hydrate thereof, and a pharmaceutical composition comprising the compound for treating a coronavirus infection. 2. The method according to claim 1 , wherein the coronavirus is SARS coronavirus (SARS-CoV) or SARS-CoV-2.3. The method according to claim 2 , wherein the coronavirus is SARS-CoV-2.4. The method according to claim 1 , wherein the disease caused by the coronavirus is a disease caused by a SARS-CoV-2 claim 1 , namely COVID-19.5. The method according to claim 1 , wherein the disease caused by the coronavirus is atypical pneumonia caused by a SARS coronavirus (SARS-CoV).6. The method according to claim 1 , wherein the disease caused by the coronavirus is a respiratory disease.7. The method according to claim 1 , wherein the disease caused by the coronavirus is simple infection claim 1 , pneumonia claim 1 , acute respiratory infections claim 1 , severe acute respiratory infection (SARI) claim 1 , hypoxic respiratory failure claim 1 , acute respiratory distress syndrome claim 1 , sepsis claim 1 , septic shock claim 1 , or severe acute respiratory syndrome (SARS).8. The method according to claim 7 , wherein the simple infection is fever claim 7 , cough and/or sore throat.9. The method according to claim 1 , wherein the mammal is bovine claim 1 , equine claim 1 , caprid claim 1 , suidae claim 1 , canine claim 1 , feline claim 1 , rodent or primate.10. The method according to claim 9 , wherein the mammal is human claim 9 , cat claim 9 , dog or pig.12. The method according to claim 11 , wherein the coronavirus is SARS coronavirus (SARS-CoV) or SARS-CoV-2.13. The method according to claim 12 , wherein the coronavirus is SARS-CoV-2.14. The method according to claim 11 , wherein the disease caused by the coronavirus is a disease caused by a SARS-CoV-2 claim 11 , namely COVID-19.15. The method according to claim ...

SYSTEM AND METHOD FOR PANORAMIC IMAGING

Provided herein are systems and methods for panoramic imaging. The present system includes multiple digital cameras having overlapping fields of view. The system further includes a control system that controls the geometry and action of the cameras to capture digital images or streams of image frames. The system further includes an image processing algorithm, the execution of which processes image inputs by the cameras into panoramic still images or movies in real time. The present method includes the steps of acquiring image information by multiple digital cameras having overlapping fields of view, analyzing each pair of image inputs having an overlapping field to identify an optimum line that makes the total error introduced by cutting and stitching the pair of image inputs along the line to be the minimum; and cutting and stitching the image inputs to generate panoramic images or movies. 1. A method for generating panoramic digital representation of an area , comprising(1) acquiring an image from each of a plurality of digital cameras having a field of view that overlaps with the field of view of at least one other digital camera among the plurality of digital cameras;(2) establishing spherical coordinates for pixels of each acquired image,(3) rearranging the pixels of each acquired image in a plane according to the spherical coordinates, thereby generating a set of planar images having one or more overlapping fields,(4) in each overlapping field among the one or more overlapping fields, identifying pixels of interest and finding an optimum line that avoids the pixels of interest, thereby generating a set of optimum lines for the set of planar images,(5) cutting and stitching the set of planar images along the set of optimum lines, thereby generating a panoramic digital representation of the area.2. The method of claim 1 , wherein step (2) is performed byestablishing a spherical coordinate system for each acquired image in a sphere tangential to the acquired ...

METHOD AND APPARATUS TO DETECT SCRIPTED NETWORK TRAFFIC

A bot traffic detection system detects scripted network traffic. The bot traffic detection system may use a one-sided unsupervised machine learning technique to estimate distributions for human, non-scripted traffic (clean distributions). The clean distributions may be dynamically updated based on the latest traffic patterns. To estimate the clean distributions the bot traffic detection system may identify, for a certain subset of network traffic, feature values of the certain subset of network traffic that do not include bot traffic (clean buckets). Using clean traffic may provide more robust and stable behavior that can be tracked over time. Using the clean distributions, the bot traffic detection system may generate a rules table that indicates a likelihood that network traffic with a given combination of feature values is scripted network traffic. The bot traffic detection system may apply the rules table in real time to identify scripted network traffic. 1. A method for detecting bot traffic , the method comprising:accessing a set of conditional independence relationships, wherein a conditional independence relationship describes a set of features that are independent of a separate feature conditioned on a subset feature;identifying clean buckets within network traffic data using the set of conditional independence relationships, wherein the network traffic data includes values for features of network traffic and the values for the features are categorized into buckets;determining clean distributions using the clean buckets; anddetecting the bot traffic based on the clean distributions.2. The method of claim 1 , further comprising: obtaining the values for the features of the network traffic through device fingerprinting.3. The method of claim 2 , wherein the features of the network traffic include geo-location information claim 2 , session information claim 2 , browser information claim 2 , and network information.4. The method of claim 3 , wherein the ...

Estimating treatment effect of user interface changes using a state-space model

Examples described herein generally relate to a computer device including a memory, and at least one processor configured to evaluate a change to a user interface. The computer device monitor user interactions with the user interface prior to and after a change to the user interface. The monitoring includes collecting result metric data per user. The computer device divides users into a treated group and a control group based on whether each user engages in a particular interaction. The computer device generates a result metric time series for the treated group and a partitioned result metric time series for the control group. The computer device estimates a conditional distribution of the result metric and a counterfactual behavior using a Bayesian machine learning model based on the result metric time series. The computer device determines a treatment effect of the change to the user interface on the result metric data.

Agomelatine halide complex, corresponding to a naphthalene derivative; procedure for preparing it.

COMPLEJO DE HALURO DE HIDRÓGENO DE AGOMELATINA, QUE COMPRENDE LA ESTRUCTURA SIGUIENTE: EN EL QUE X ES HALÓGENO; Y PROCEDIMIENTO DE PREPARACIÓN DEL MISMO. AGOMELATIN HYDROGEN HALIDE COMPLEX, INCLUDING THE FOLLOWING STRUCTURE: IN WHICH X IS HALOGEN; AND PROCEDURE OF PREPARATION OF THE SAME.

Methods for detecting bacteriophage MS2

The present invention relates to methods and assays for detecting bacteriophage MS2 in a sample.

Novel nucleic acids and polypeptides

Published without an Abstract

Crystal form vi of agomelatine; Preparation process; pharmaceutical composition; and its use to treat stress, anxiety, sleep disorders, cardiovascular diseases, schizophrenia, phobia, depression, diseases of the digestive system.

Forma cristalina VI de la agomelatina; proceso de preparación; composición farmacéutica; y su uso para enfermedades del sistema melatoninérgico, trastorno del sueño, estrés, ansiedad, entre otros. Crystalline form VI of agomelatine; Preparation process; pharmaceutical composition; and its use for diseases of the melatoninergic system, sleep disorder, stress, anxiety, among others.

Methods for detecting bacteriophage MS2

The present invention relates to methods and assays for detecting bacteriophage MS2 in a sample.

Methods for detecting bacteriophage MS2

The present invention relates to methods and assays for detecting bacteriophage MS2 in a sample.

Methods for detecting bacteriophage MS2

The present invention relates to methods and assays for detecting bacteriophage MS2 in a sample.

Humanized anit-egfr antibody l4-h3 and coding gene thereof

The present invention discloses a humanized anti-EGFR antibody L4-H3 and coding gene thereof. The antibody is composed of a heavy chain and a light chain, wherein the amino acid sequence of the heavy chain variable region is shown as positions 1-145 of SEQ ID NO: 3, the heavy chain constant region is the heavy chain constant region of the human antibody IgG1, and the amino acid sequence of the light chain is shown as SEQ ID NO: 1.

Use of favipiravir in treatment of coronavirus infection

The present application relates to a Favipiravir compound represented by Formula I, a geometric isomer, a pharmaceutically acceptable salt, a solvate and/or a hydrate thereof, and a pharmaceutical composition comprising the compound for treating a coronavirus infection.

Crystal form of pyridine nitrogen oxide compound and use thereof

A crystal form of a pyridine nitrogen oxide compound and the use thereof. Specifically, the present invention relates to a crystal form of a compound of formula (I), a pharmaceutical composition and the use thereof.

太陽電池及び光起電力モジュール

【課題】本願は、太陽電池及び光起電力モジュールに関する。 【解決手段】太陽電池は、基板及び基板に位置するパッシベーション層と、基板の面に設けられたメイングリッド及びサブグリッドとを含み、メイングリッドとサブグリッドは電気的に接続され、サブグリッドは基板に電気的に接続され、メイングリッドの数は１０～１５本であり、太陽電池は基板の面に設けられた溶接点をさらに含み、溶接点の数は４～６個であり、溶接点は第１溶接点及び第２溶接点を含み、第１溶接点はメイングリッドの両端に位置し、第２溶接点は第１溶接点の間に位置し、第１溶接点の面積は０．６ｍｍ ２ ～１．３ｍｍ ２ であり、第２溶接点の面積は０．２ｍｍ ２ ～０．５ｍｍ ２ である。 【選択図】図１

太陽電池及び光起電力モジュール

【課題】本願は、太陽電池及び光起電力モジュールに関する。 【解決手段】太陽電池は、基板及び基板に位置するパッシベーション層と、基板の面に設けられたメイングリッド及びサブグリッドとを含み、メイングリッドとサブグリッドは電気的に接続され、サブグリッドは基板に電気的に接続され、メイングリッドの数は１０～１５本であり、太陽電池は基板の面に設けられた溶接点をさらに含み、溶接点の数は４～６個であり、溶接点は第１溶接点及び第２溶接点を含み、第１溶接点はメイングリッドの両端に位置し、第２溶接点は第１溶接点の間に位置し、第１溶接点の面積は０．６ｍｍ ２ ～１．３ｍｍ ２ であり、第２溶接点の面積は０．２ｍｍ ２ ～０．５ｍｍ ２ である。 【選択図】図１

Single-motor, dual-hydraulic-circuit drive system for industrial materials-handling vehicle and method for controlling the same

A drive system (100) for an industrial handling vehicle comprises an electric motor (200), a first pump (300), for example, a plunger pump, and a second pump (400), for example, a gear pump. The first pump (300) is configured to provide hydraulic power for a travelling device of the industrial handling vehicle. The first pump (300) and the travelling device are in a first hydraulic circuit. The second pump (400) is configured to provide hydraulic power for a brake device (600) and/or a steering device (800) and/or a handling device (700) of the industrial handling vehicle. The second pump (400), the brake device (600), the steering device (800), and the handling device (700) are in a second hydraulic circuit isolated from the first hydraulic circuit. The electric motor (200) is operatively coupled to both the first pump (300) and the second pump (400), to drive them to operate.

コロナウイルス感染の治療におけるファビピラビルの使用

【課題】コロナウイルス、特にSARSコロナウイルス（SARS-CoV）およびSARS-CoV-2の感染により引き起こされる関連疾患の治療に用いることができる、コロナウイルスに対して抗ウイルス活性を有する薬を提供すること。【解決手段】コロナウイルス感染を治療するための、式Ｉにより表されるファビピラビル化合物、その幾何異性体、薬学的に許容される塩塩、溶媒和物および／または水和物、並びに該化合物を含む医薬組成物。TIFF2024003097000022.tif2760【選択図】図１

Fully-electric fixed non-drop wheel lathe

Forma cristalina de un compuesto de óxido de nitrógeno de piridina y uso de la misma

Un forma cristalina de un compuesto de óxido de nitrógeno de piridina y el uso de la misma. Específicamente, la presente invención se refiere a una forma cristalina de un compuesto de fórmula (I), una composición farmacéutica y un uso de la misma.

Crystal form of pyridine nitrogen oxide compound and use thereof

A crystal form of a pyridine nitrogen oxide compound and the use thereof. Specifically, the present invention relates to a crystal form of a compound of formula (I), a pharmaceutical composition and the use thereof.

Forma cristalina de un compuesto de óxido de nitrógeno de piridina y uso de la misma

A crystal form of a pyridine nitrogen oxide compound and the use thereof. Specifically, the present invention relates to a crystal form of a compound of formula (I), a pharmaceutical composition and the use thereof.

Forma de cristal de composto de óxido de nitrogênio e piridina e uso da mesma

forma de cristal de composto de óxido de nitrogênio e piridina e uso da mesma. trata-se de uma forma de cristal de um composto de óxido de nitrogênio e piridina e uso da mesma. especificamente, a presente invenção se refere a uma forma de cristal de um composto de fórmula (i), uma composição farmacêutica e um uso da mesma.

セル、光起電力モジュール及び光起電力モジュールの製造方法

【課題】セル、光起電力モジュール及び光起電力モジュールの製造方法を提供する。【解決手段】セルは、基板と、基板に設けられた第１メイングリッド線及び第２メイングリッド線と、第１メイングリッド線に接続された第１細グリッド線と、第２メイングリッド線に接続された第２細グリッド線とを含み、第１メイングリッド線と第２メイングリッド線は極性が逆であり、第１細グリッド線と第１メイングリッド線、第２細グリッド線と第２メイングリッド線は、極性が同じであり、基板にメイングリッドピットが設けられ、第１メイングリッド線の少なくとも一部、第２メイングリッド線の少なくとも一部がメイングリッドピット内に位置し、メイングリッドピットの深さが３０μｍ～５０μｍであり、基板の厚さ方向に沿って、メイングリッドピットの深さと第１メイングリッド線及び／又は第２メイングリッド線の高さの割合範囲が１０：３～６：５である。【選択図】図８

Estimating treatment effect of user interface changes using a state-space model

Examples described herein generally relate to a computer device including a memory, and at least one processor configured to evaluate a change to a user interface. The computer device monitor user interactions with the user interface prior to and after a change to the user interface. The monitoring includes collecting result metric data per user. The computer device divides users into a treated group and a control group based on whether each user engages in a particular interaction. The computer device generates a result metric time series for the treated group and a partitioned result metric time series for the control group. The computer device estimates a conditional distribution of the result metric and a counterfactual behavior using a Bayesian machine learning model based on the result metric time series. The computer device determines a treatment effect of the change to the user interface on the result metric data.

Electronic device and inductive charging module thereof

一种t型三电平变流器的控制装置

本申请公开了一种T型三电平变流器的控制装置，包括：底板，底板上表面的中央位置设置有直流母线电容组，底板上表面在以直流母线电容组为轴线对称的两侧分别设置有与直流母线电容组电气连通的整流模块和逆变模块，底板上表面在以直流母线电容组为轴线对称的两侧还分别设置有能够反馈整流模块的工作参数和逆变模块的工作参数的第一电流传感器和第二电流传感器，底板的上表面还设置有用于根据第一电流传感器的工作参数和第二电流传感器的工作参数输出整流模块和/或逆变模块的工作状态，以使得直流母线的中点电位处于平衡状态的控制器。该装置可以相对降低T型三电平变流器在工作过程中直流母线电容组的直流母线发生中点电位不平衡的概率。

一种t型三电平变流器的散热结构及t型三电平变流器

本申请公开了一种T型三电平变流器的散热结构，包括：贴合在T型三电平变流器中散热元件的底部，用于吸收散热元件散发热气流的基板，基板上设置有通风管道，并且，通风管道的横截面垂直于基板的水平面，通风管道内部沿着通风管道的通风方向上设置有多个相互平行且均匀分布的散热翅片，通风管道的管道一端设置有用于将制冷装置散发的制冷气流引入通风管道的进风口。显然，因为T型三电平变流器中散热元件的热气流都是从通风管道内部的多个散热翅片进行散热的，这样散热元件的热气流就能够集中通过通风管道中的多个散热翅片进行散热，由此就可以显著提高散热结构的散热效率。相应的，本申请所提供的一种T型三电平变流器同样具有上述有益效果。

Forma cristalina de un compuesto de oxido de nitrogeno de piridina y uso de la misma.

Un forma cristalina de un compuesto de óxido de nitrógeno de piridina y el uso de la misma. Específicamente, la presente invención se refiere a una forma cristalina de un compuesto de fórmula (I), una composición farmacéutica y un uso de la misma. (ver Fórmula).

All-electric fixed underfloor wheel sets lathe

Disclosed is an all-electric fixed underfloor wheel sets lathe, comprising: a frame, two rails provided on the frame, two lathe tools provided on the frame and two sets of wheel driving devices provided on the frame, wherein each set of the wheel driving devices comprises leveling brackets, drive assemblies provided on the leveling brackets, lifting assemblies provided on the leveling brackets and leveling assemblies provided on the leveling brackets, the lifting assemblies and the leveling assemblies are fixedly connected to the frame, the drive assemblies are configured for driving wheels to rotate and the lifting assemblies are configured for lifting the leveling brackets.

Estimating treatment effect of user interface changes using a state-space model

Examples described herein generally relate to a computer device including a memory, and at least one processor configured to evaluate a change to a user interface. The computer device monitor user interactions with the user interface prior to and after a change to the user interface. The monitoring includes collecting result metric data per user. The computer device divides users into a treated group and a control group based on whether each user engages in a particular interaction. The computer device generates a result metric time series for the treated group and a partitioned result metric time series for the control group. The computer device estimates a conditional distribution of the result metric and a counterfactual behavior using a Bayesian machine learning model based on the result metric time series. The computer device determines a treatment effect of the change to the user interface on the result metric data.

High-speed processing mechanism of packet-switching

An apparatus

An apparatus comprises a substantially horn shaped structure configured to amplify sound from a speaker of a device wherein the apparatus comprises packaging of the device.

Crystal form of pyridine nitrogen oxide compound and use thereof

A crystal form of a pyridine nitrogen oxide compound and the use thereof. Specifically, the present invention relates to a crystal form of a compound of formula (I), a pharmaceutical composition and the use thereof.

Powder for compressor end cover and preparation method thereof

Crystal form of pyridine nitrogen oxide compound and use thereof

A crystal form of a pyridine nitrogen oxide compound and the use thereof. Specifically, the present invention relates to a crystal form of a compound of formula (I), a pharmaceutical composition and the use thereof.

Automatic testing tool for standard management interface of SNMP capable of supporting IPv4 and IPv6

扣件結構

Packaging container

Optimized design method and system for carbon dioxide geological storage parameters in depleted gas reservoir

An optimized design method and system for carbon dioxide geological storage parameters of a depleted gas reservoir is provided, including: collecting data of a depleted gas reservoir in which carbon dioxide geological storage is to be carried out, and establishing a numerical simulation model of the depleted gas reservoir; carrying out fitting of production performance history to obtain current state information; simulating and predicting production performance data after carbon dioxide injection into depleted oil and gas reservoirs under different combinations of well pattern parameters and injection parameters using a numerical simulation technology; calculating a parameter value representing a uniform pressure rise according to the production performance data; updating well pattern parameters and injection parameters using a genetic algorithm; repeating above steps until an iterative convergence condition is met; and determining an optimal combination of carbon dioxide injection process parameters according to an output optimal target value.

Crystal form of pyridine nitrogen oxide compound and use thereof

A crystal form of a pyridine nitrogen oxide compound and the use thereof. Specifically, the present invention relates to a crystal form of a compound of formula (I), a pharmaceutical composition and the use thereof.